Assertio Holdings (ASRT) Free Cash Flow (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Free Cash Flow came in at $8.6 million in Q1 2026, up 168.3% year-on-year from $3.2 million in Q1 2025, and up 128.57% quarter-over-quarter from -$30.0 million in Q4 2025.
Assertio Holdings (ASRT) Free Cash Flow (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Free Cash Flow across 8 years of filings, most recently posting $8.6 million for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $8.6 million, up 168.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 211.3% YoY), and the FY2025 annual result was -$28.2 million, down 206.72% from the prior year.
- Free Cash Flow came in at $8.6 million for Q1 2026 at Assertio Holdings, up from -$30.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $27.4 million in Q1 2022 to a low of -$30.0 million in Q4 2025.
- The 5-year median for Free Cash Flow is $8.6 million (2026), against an average of $7.9 million.
- Across the five-year window, Free Cash Flow jumped 1396.89% in 2022 and tumbled 13520.0% in 2025, its largest moves.
- Assertio Holdings' Free Cash Flow stood at $26.4 million in 2022, then plunged by 79.72% to $5.4 million in 2023, then surged by 115.49% to $11.5 million in 2024, then slumped by 359.51% to -$30.0 million in 2025, then jumped by 128.57% to $8.6 million in 2026.
- The last three Free Cash Flow figures came in at $8.6 million (Q1 2026), -$30.0 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 8.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.56 Mn |
| Mar 31, 2026 | 8.56 Mn |
| Dec 31, 2025 | -29.97 Mn |
| Dec 31, 2025 | -29.97 Mn |
| Sep 30, 2025 | -4.77 Mn |
| Sep 30, 2025 | -4.77 Mn |
| Jun 30, 2025 | 19.09 Mn |
| Jun 30, 2025 | 19.09 Mn |
| Mar 31, 2025 | -12.54 Mn |
| Mar 31, 2025 | -12.54 Mn |
| Dec 31, 2024 | 11.55 Mn |
| Dec 31, 2024 | 11.55 Mn |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | 7.39 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 5.36 Mn |
| Dec 31, 2023 | 5.36 Mn |